Pomegranate Health
A podcast about the culture of medicine.
You'll hear clinicians, researchers and advocates discuss all aspects of professional practice healthcare. This includes clinical judgement, ethics, diagnostic bias, better communication and more equitable health systems.
For a sampler of these diverse themes take a listen to Episode 132 and Episode 135.
If RACP is your CPD home, you can log time spent listening to each episode with the "Add educational activity to MyCPD" button at each episode page.
And if you're a Basic Physician Trainee, the [Case Report] series might help you prepare for your long case clinical exams. For more information on other episode formats click About Pomegranate.
Feel free to leave feedback in the comments section for each episode or send it to us via email at podcast@racp.edu.au.
Latest episodes
Ep128: Brushing off the cobwebs
Taking long breaks from medicine for can lead to loss of skills and confidence. Simulation training is an effective way to brush off the cobwebs before returning to practice.
Ep126: Trying times for Māori medics
Medical schools in Aotearoa-New Zealand have turbocharged their intake of Māori and Pasifika students but these graduates have not trickled through to the RACP’s training programs in great numbers. We take a look at the culture of training environments and also the recent politicking over Māori self-governance.
[Case Report] 52yo with hand clumsiness after Chiari operation
52-year-old female presenting with clumsiness and paresthesia of the right hand had three weeks prior undergone a suboccipital craniotomy for a Chiari malformation. She had accompanying headaches, but there was a past medical history of migraines and a family history of a Factor V Leiden mutation.
Ep124: Pleural medicine comes of age
Professor Gary Lee established the first dedicated pleural service in the southern hemisphere in 2009. In this podcast he summarises key developments in the management of pleural disease over the last thirty years.
Ep122: Funding pan-cancer therapies
Tissue-agnostic therapies may be a godsend for people with rare cancers and cancers of unknown origin, but regulatory and funding frameworks haven’t kept up with the scientific revolution.
Ep121: Precision oncology explained
Genomics has allowed increasingly rapid development highly-targeted cancer drugs and unprecedented improvements in outcomes for patients with more common cancers. Now, patients with rare cancers also have some hope in the form of tissue-agnostic therapies.